OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sparsentan: the first and only non-immunosuppressive therapy for the reduction of proteinuria in IgA nephropathy
Howard Trachtman, Radko Komers, Jula K. Inrig
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 6, pp. 571-576
Open Access | Times Cited: 7

Showing 7 citing articles:

Real-world assessment of sparsentan’s drug safety framework
Wenjing Fu, Jingyu Wang, Yuzhou Xue, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access

The Rapidly Changing Treatment Landscape of IgA Nephropathy
Chee Kay Cheung, Jonathan Barratt
Seminars in Nephrology (2025), pp. 151573-151573
Closed Access

Polypharmacology: new drugs in 2023–2024
Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker
Pharmacological Reports (2025)
Open Access

Endothelin Inhibitors in Chronic Kidney Disease: New Treatment Prospects
Agata Rakotoarison, Marta Kepinská, Andrzej Konieczny, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 20, pp. 6056-6056
Open Access | Times Cited: 2

Advancements in understanding the role of intestinal dysbacteriosis mediated mucosal immunity in IgA nephropathy
Yitao Fan, Yan Wang, Xiao Han, et al.
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1

The mechanism of action and chemical synthesis of FDA newly approved drug molecules
Dandan Shen, Yuelin Zhang, Xiang Li, et al.
Drug Development Research (2024) Vol. 85, Iss. 6
Closed Access

Page 1

Scroll to top